Sign in

CIK 0001108205

  • Non-accelerated filer
  • Smaller reporting company
Ticker
CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043505116
Phone
+1 617-503-6500
Business address
128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 41 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2004-01-07 NOEL MARK Vice President, Tech. Manage. Sale −500 $5.03 $3K 0
2004-01-07 NOEL MARK Vice President, Tech. Manage. Sale −1,800 $5.11 $9K 9,375
2004-01-07 NOEL MARK Vice President, Tech. Manage. Exercise or conversion · Non-Qualified Stock Option (Right to Buy) −4,000 $0.84 $3K 21,000
2003-11-03 KAITIN KENNETH I Director Grant or award · Non-qualified stock option (right to buy) +25,000 $4.75 $119K 25,000
2003-07-08 DAVIE JOSEPH M Director Grant or award · Non-qualified stock option (right to buy) +25,000 $3.63 $91K 0
2003-07-08 DAVIE JOSEPH M Director Grant or award · Non-qualified stock option (right to buy) +105,000 $3.63 $381K 130,000
2003-01-16 POTTHOFF MARY ELIZABETH Vice President,General Counsel Sale −5,000 $6.25 $31K 0

Page 57 of 57 · 1,127 trades